Cost-Effectiveness of Treatments for Wet Age-Related Macular Degeneration (Wamd) In The Netherlands, The Case of Intravitreal Aflibercept (Ivt-Afl) and Ranibizumab
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.554
https://www.valueinhealthjournal.com/article/S1098-3015(15)02630-3/fulltext
Title :
Cost-Effectiveness of Treatments for Wet Age-Related Macular Degeneration (Wamd) In The Netherlands, The Case of Intravitreal Aflibercept (Ivt-Afl) and Ranibizumab
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02630-3&doi=10.1016/j.jval.2015.09.554
First page :
A420
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
470